1. Home
  2. NMP vs CGTX Comparison

NMP vs CGTX Comparison

Compare NMP & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NMP

NMP Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.00

Market Cap

160.5M

Sector

Finance

ML Signal

N/A

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.72

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMP
CGTX
Founded
2024
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.5M
158.8M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
NMP
CGTX
Price
$10.00
$1.72
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.88
AVG Volume (30 Days)
59.2K
978.2K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.90
$0.22
52 Week High
$10.07
$3.83

Technical Indicators

Market Signals
Indicator
NMP
CGTX
Relative Strength Index (RSI) N/A 54.36
Support Level N/A $1.58
Resistance Level N/A $1.81
Average True Range (ATR) 0.00 0.13
MACD 0.00 0.03
Stochastic Oscillator 0.00 82.30

Price Performance

Historical Comparison
NMP
CGTX

About NMP NMP Acquisition Corp. Class A Ordinary Shares

NMP Acquisition Corp is a blank check company.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: